India Globalization Capital, Inc. (NYSE: IGC) to Launch Medical Dispensary Product for Alzheimer’s Disease
Product portfolio to include drugs and supplements Faster monetization of lead Alzheimer’s candidate as supplement Market valuation poised to soar It should come as no surprise to discover that the medical cannabis dispensary product line in America is getting increasingly diverse and sophisticated. After all, the cannabis sativa plant incorporates over 400 chemical entities, of which more than 60 are cannabinoids. Even though cannabis has been used and cultivated by mankind for at least 6,000 years, it was only relatively recently, in 1899, that the first cannabinoid, cannabinol (CBN), was identified and isolated. With so much chemistry wrapped in its…